26.56
Schlusskurs vom Vortag:
$26.34
Offen:
$26.54
24-Stunden-Volumen:
943.16K
Relative Volume:
1.18
Marktkapitalisierung:
$2.16B
Einnahmen:
$1.93B
Nettoeinkommen (Verlust:
$174.22M
KGV:
12.95
EPS:
2.0516
Netto-Cashflow:
$237.32M
1W Leistung:
+1.61%
1M Leistung:
+1.65%
6M Leistung:
+20.89%
1J Leistung:
+66.00%
Pediatrix Medical Group Inc Stock (MD) Company Profile
Firmenname
Pediatrix Medical Group Inc
Sektor
Branche
Telefon
(954) 384-0175
Adresse
1301 CONCORD TERRACE, SUNRISE, FL
Compare MD vs HCA, THC, FMS, EHC, DVA
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
MD
Pediatrix Medical Group Inc
|
26.56 | 2.14B | 1.93B | 174.22M | 237.32M | 2.0516 |
|
HCA
Hca Healthcare Inc
|
411.73 | 87.68B | 76.39B | 7.81B | 7.93B | 29.08 |
|
THC
Tenet Healthcare Corp
|
270.21 | 21.30B | 21.46B | 2.65B | 3.35B | 19.23 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.56 | 12.51B | 22.44B | 1.35B | 2.03B | 1.9002 |
|
EHC
Encompass Health Corp
|
122.10 | 12.03B | 6.07B | 793.80M | 464.40M | 5.9914 |
|
DVA
Davita Inc
|
177.91 | 11.27B | 13.84B | 1.10B | 1.49B | 10.42 |
Pediatrix Medical Group Inc Stock (MD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-16 | Eingeleitet | Macquarie | Outperform |
| 2024-09-26 | Hochstufung | Jefferies | Hold → Buy |
| 2024-06-07 | Hochstufung | Deutsche Bank | Sell → Hold |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-06-23 | Fortgesetzt | Stifel | Hold |
| 2020-10-19 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2020-01-03 | Herabstufung | Citigroup | Buy → Neutral |
| 2019-12-12 | Hochstufung | Stifel | Hold → Buy |
| 2019-09-06 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-01-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Hold |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-09-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-09-18 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2018-08-03 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-07-12 | Eingeleitet | Leerink Partners | Mkt Perform |
| 2018-03-27 | Eingeleitet | Credit Suisse | Neutral |
| 2018-02-12 | Bestätigt | Mizuho | Neutral |
| 2017-12-13 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-09-18 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2017-05-30 | Bestätigt | Mizuho | Neutral |
| 2017-05-25 | Bestätigt | Stifel | Hold |
| 2017-05-04 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2017-03-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2017-03-10 | Herabstufung | JP Morgan | Overweight → Neutral |
Alle ansehen
Pediatrix Medical Group Inc Aktie (MD) Neueste Nachrichten
Pediatrix (MD) Results Review: EPS Lands Above Forecast in the Latest Reading; Closing Move: Shares Finish 0.84% HigherEarnings Deceleration Risk - Vinanet
Jefferies downgrades Pediatrix Medical stock rating on valuation By Investing.com - Investing.com Canada
Pediatrix (MD) Trading-Day Recap: Ends Higher by 0.84% at $26.56 on the Day; Level Position: Support at $25.23 and Resistance at $27.89 Frame the RangeReversal Trade - Vinanet
Pediatrix Medical Group (MD) Slips 1.5% as Shares Test Key Technical LevelsMFI Divergence - Vinanet
Will Earnings Beat and Major Buybacks Change Pediatrix Medical Group's (MD) Narrative - simplywall.st
Pediatrix Medical Group (NYSE:MD): A Value Stock with a Clear Margin of Safety - ChartMill
Pediatrix Medical Group, Inc. SEC Filing (Aug 14, 2026) - stocktitan.net
Pediatrix Medical Group (MD) director awarded 472 restricted shares and reports trust holdings - stocktitan.net
Pediatrix Medical Group (MD) director receives 472 restricted shares in equity grant - stocktitan.net
Pediatrix Medical Group (MD) director receives 472-share restricted stock grant - stocktitan.net
Pediatrix Medical Group (MD) grants 472 restricted shares to director Sansone - stocktitan.net
Pediatrix Medical Group (MD) director gets 472-share equity grant - stocktitan.net
Pediatrix Medical Group (MD) director awarded 472 restricted shares in equity grant - stocktitan.net
Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio - Yahoo Finance
Pediatrix Medical Group, Inc. Stock 12‑Month Price Target Cut to $26, Implies 2% Downside - tradingview.com
5 Must-Read Analyst Questions From Pediatrix Medical Group’s Q2 Earnings Call - Yahoo Finance
Pediatrix Medical Group, Inc. (MD) Stock Forecasts - Yahoo Finance
Wasatch Advisors LP Boosts Stake in Pediatrix Medical Group, Inc. $MD - MarketBeat
Pediatrix Medical Group (MD) Q2 2026 Earnings Call Transcript - AOL.com
Pediatrix Medical Group, Inc. (MD) Stock Analysis: Understanding the Healthcare Stock’s Growth Potential and Analyst Ratings - DirectorsTalk Interviews
Pediatrix Medical Group (MD) Stock Seems Undervalued While Its 89% Return Raises Questions - Sahm
Pediatrix Medical Group (MD) Earnings Growth Puts Its Valuation Back In Focus - Yahoo Finance
Is Stronger Q2 2026 EPS From Operations Altering The Investment Case For Pediatrix Medical Group (MD)? - Yahoo Finance
Does Pediatrix’s Modest Profit Uptick Reveal a Deeper Shift in MD’s Efficiency Story? - simplywall.st
Sei Investments Co. Cuts Stock Holdings in Pediatrix Medical Group, Inc. $MD - MarketBeat
Pediatrix Medical Tops Q2 Earnings on Better Cash Collections - Zacks Investment Research
UBS Adjusts Price Target on Pediatrix Medical to $28 From $25, Maintains Neutral Rating - marketscreener.com
Pediatrix Medical Group, Inc. (NYSE:MD) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Full Transcript: Pediatrix Medical Group Q2 2026 Earnings Call - Sahm
Deutsche Bank Adjusts Pediatrix Medical Price Target to $25 From $19, Maintains Hold Rating - marketscreener.com
Insiders At Pediatrix Medical Group Sold US$1.8m In Stock, Alluding To Potential Weakness - Moomoo
Pediatrix Medical Group Q2 Earnings Call Highlights - MarketBeat
Pediatrix Medical Group (MD) Stock Slides As Volume Weakness Clouds EPS Gain - Sahm
Pediatrix Medical Group Inc (MD) (Q2 2026) Earnings Call Highlig - GuruFocus
Pediatrix Medical Group, Inc. Q2 2026 Earnings Call Summary - finance.yahoo.com
Pediatrix Medical Group Inc (MD) (Q2 2026) Earnings Call Highlights: Strong EBITDA and Payer ... - Yahoo Finance
Why Pediatrix Medical Group (MD) Shares Are Trading Lower Today - The Globe and Mail
Pediatrix Medical Group (NYSE:MD) Shares Gap DownWhat's Next? - MarketBeat
Pediatrix Medical Group, Inc. Q2 2026 Financial Results: Earnings, Risk Factors & SEC Filings Overview - Minichart
Earnings call transcript: Pediatrix beats Q2 2026 estimates, shares slip By Investing.com - Investing.com Nigeria
Is Pediatrix Medical Group Inc (MD) Misaligned with Fundamental - GuruFocus
Earnings call transcript: Pediatrix beats Q2 2026 estimates, shares slip - Investing.com
Pediatrix Medical Group Inc reports results for the quarter ended June 30Earnings Summary - tradingview.com
Q2 2026 Pediatrix Medical Group Inc Earnings Call Transcript - GuruFocus
Pediatrix Medical Q2 Adjusted Earnings, Revenue Rise; Shares Fall Pre-Bell - marketscreener.com
Pediatrix Medical Group (MD) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Pediatrix Medical beats Q2 estimates, reaffirms guidance By Investing.com - Investing.com Canada
Pediatrix Medical Group’s (NYSE:MD) Q2 CY2026: Beats On Revenue But Stock Drops 12.3% - Yahoo Finance
Pediatrix Medical Group Reports Second Quarter Results - Business Wire
Pediatrix Medical Group, Inc. (MD) Stock Analysis: Evaluating the Healthcare Specialist with a Strong ROE and Market Position - DirectorsTalk Interviews
Pediatrix Medical beats Q2 revenue estimates, reaffirms 2026 adjusted EBITDA outlook - Bitget
Finanzdaten der Pediatrix Medical Group Inc-Aktie (MD)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):